Cyclerion Therapeutics (CYCN) Non Operating Income (2020 - 2025)

Cyclerion Therapeutics' Non Operating Income history runs 6 years deep, the most recent figure standing at $30000.0 for Q3 2025.

• In Q3 2025, Non Operating Income fell 92.59% year-over-year to $30000.0; the TTM figure through Sep 2025 stood at $1.4 million (up 122.67% YoY), while the FY2024 annual figure was $571000.0, up 59.5% from the prior year.
• Non Operating Income was $30000.0 for Q3 2025 at Cyclerion Therapeutics, down from $1.3 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $1.3 million in Q2 2025 to a low of -$6000.0 in Q2 2021.
• Historically, Non Operating Income has averaged $137526.3 across 5 years, with a median of $62000.0 in 2023.
• The sharpest annual moves came in 2021 and 2022: Non Operating Income tumbled 105.38% in 2021, then surged 13300.0% in 2022.
• A 5-year view of Non Operating Income shows it stood at -$1000.0 in 2021, then soared by 13300.0% to $132000.0 in 2022, then retreated by 23.48% to $101000.0 in 2023, then sank by 72.28% to $28000.0 in 2024, then rose by 7.14% to $30000.0 in 2025.
• The last three Non Operating Income figures came in at $30000.0 (Q3 2025), $1.3 million (Q2 2025), and $28000.0 (Q1 2025), per Business Quant data.